Researchers have developed a new gene-editing platform that could make T cell–based immunotherapies safer and more effective for treating cancer. Dr Jesse Armitage, from The University of ...

The publication, titled " Salvage therapy with allogeneic invariant natural killer T cells in a heavily pre-treated germ cell tumor," presents a patient case from MiNK's clinical trial (NCT05108623).

The publication, authored by leading experts in iNKT biology, underscores the power of iNKT cells as the next-generation off-the-shelf platform for treating solid tumors-where conventional cell ...

Cutting edge research found that putting the gastrointestinal tract under stress can knock out healthy bacteria - making your body more susceptible to aggressive tumors.